m+Medelevator.RU
← Поиск публикаций
Materials today. Bio · 2026

In situ engineered silicon-magnesium implants orchestrate sequential immunomodulation, angiogenesis, and osteogenesis for bone repair.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Qiang Weipeng, Chen Mi, Ma Hongyun, Ai Minhui, Tian Jing, Zhang Zuhao, Huang Qian, Su Xiaochen, Jung Hyun-Do, Lei Bo

Аннотация

Magnesium (Mg) is a promising candidate for next-generation bone implants due to its favorable mechanical properties and biodegradability. However, its rapid corrosion causes local alkalization, hydrogen release, and inflammation, severely limiting clinical translation. Herein, we developed a multifunctional Mg-based implant, denoted as Mg/Mg2SiO4/PDA (MSP), by constructing an in situ Mg2SiO4 interlayer on the Mg substrate through a one-pot hydrothermal process, followed by polydopamine (PDA) functionalization. This multilayered design orchestrates sequential bone regeneration: early antiinfection-immunoregulation and late vascularization and osteogenesis, which main arises from the different degradation rate and time-window effects of the PDA and Mg-Si layers. By harnessing a controlled initial alkaline burst, the implant effectively inhibits bacterial infection, with bacterial survival rates all below 20%, while the subsequent PDA-mediated immunomodulation promotes macrophage polarization toward the pro-regenerative M2 phenotype and suppressing pro-inflammatory cytokines. Concurrently, controlled release of Si4+ and Mg2+ from the Mg2SiO4 layer, synergized with PDA, enhances endothelial cell migration and angiogenesis. Sustained Mg2+ release further supports osteogenesis, amplified by the synergistic effects of Si4+ and PDA. MSP exhibited effective antioxidative capacity, potent antibacterial activity, and excellent cytocompatibility, with co-culture studies using rat adipose-derived stem cells (rADSCs) confirming robust osteoinduction. MSP significantly enhanced new bone formation and early-stage osseointegration, with BV/TV increased by 73% versus the Mg at 8 weeks. This innovative surface engineering strategy integrates immunoregulatory, pro-angiogenic, and osteoinductive functionalities, offering a transformative approach for Mg-based implants in bone regeneration within complex inflammatory microenvironments.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты